This site is intended for healthcare professionals
Welcome to the Psoriasis Academy
Psoriasis Academy

The Academy

Read time: 13 mins
Last updated:7th Aug 2023
Published:7th Aug 2023

What is the Psoriasis Academy?

The Psoriasis Academy is an online educational resource that has been created to help HCPs quickly learn the latest hot topics and developments in the field of psoriasis, and to help them navigate the rapidly evolving treatment landscape for patients with moderate-to-severe psoriasis.

Mission statement

The Psoriasis Academy draws on the experience of practicing dermatologists, general practitioners (GPs), and allied healthcare professionals (HCPs) around the world. It is a central repository for specialists who know the current market, but want to remain informed on the latest treatment research and development. The Psoriasis Academy aims to serve as a platform for HCPs to share clinical experiences.

Psoriasis is a debilitating, chronic inflammatory autoimmune disease, with an evolving treatment landscape that includes topical therapy, phototherapy, and systemic drugs1.

The Psoriasis Academy was created because we know that busy HCPs need to access and share important information on all aspects of the disease and its management quickly and easily.

Expert opinion

Throughout the Psoriasis Academy, look out for video footage of leading experts in the psoriasis field. Our experts have answered insightful questions on aspects of psoriasis management, which we have included throughout the Psoriasis Academy.

Meet the Experts

Dr Rachel Sommer.png

Dr Rachel Sommer

PD Dr Rachel Sommer leads the People-Centered Health Care research group at the University Medical Center Hamburg-Eppendorf. With a PhD in quality of life in rare paediatric disease, Dr Sommer completed her habilitation (assistant professorship) in health services research in dermatology in 2021. The focus of Dr Sommer’s research is people-centered health care, a key global strategy advocated by the World Health Organization. Dr Sommer’s research group investigates the subjectively experienced health of people with skin diseases, taking into account physical, psychological and social aspects.

Disclosures: Dr Sommer has received lecture/research/consultant fees and/or travel expenses from AbbVie, Almirall, Beiersdorf AG, Janssen Cilag, Leo Pharma, Novartis and UCB. Dr Sommer received honorarium from EPG Health, an IQVIA business, for reviewing and steering 2023 updates to the Psoriasis Academy content, and for participating in interviews for the Psoriasis Academy.

 

Joel Nelson BG.png

Joel Nelson

Joel is a psoriasis patient advocate and Psoriatic Disease Ambassador for the International Federation of Psoriatic Disease Associations (IFPA). With the onset of arthritis as a child and psoriasis as a young man, Joel has experienced the physical and mental health impacts of psoriatic disease for most of his life. Using his creative skills as a writer, content creator and speaker, he creates peer support spaces and builds communities to ‘meet patients where they are’, facilitating conversation to amplify and promote the value of lived experience to improve outcomes for patients.

Disclosures: Joel received honorarium from EPG Health, an IQVIA business, for participating in interviews for the Psoriasis Academy.

 

 

Professor Matthias Augustin New.pngProfessor Matthias Augustin

Professor Matthias Augustin, MD, PhD, is the Director of the Institute for Health Services Research in Dermatology and Nursing at the University of Hamburg, and former Vice Director of the Department of Dermatology and Venereology, University Medical Centre Freiburg in Germany. Professor Augustin is a founding member and a spokesperson of the regional psoriasis network in Germany (PsoNet). He has co-authored more than 620 scientific and medical papers and 27 medical textbooks, and has been a peer reviewer for 25 scientific journals, including Lancet and British Journal of Dermatology.

Disclosures: Professor Augustin has served as a consultant, lecturer, researcher, and/or has received research grants from companies manufacturing drugs for chronic skin diseases, including AbbVie, Almirall, Amgen, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Dermira, Eli Lilly, Galderma, GlaxoSmithKline, Hexal, Janssen, LEO, Medac, MSD, Mylan B.V., Novartis, Pfizer, Regeneron, Sandoz, Sanofi and UCB.

Professor Antonio Costanzo.png

Professor Antonio Costanzo

Antonio Costanzo is Full Professor of Dermatology, Chairman of Dermatology and the Director of the Skin Pathology Laboratory at Humanitas University of Milan and Member of the European Dermatology Forum Board. His clinical research is focused on the characterisation of the activity of biologics in psoriasis and psoriatic arthritis. This research is strictly linked to basic research activity on the pathogenesis of psoriasis and on the use of pharmacogenetic approach to predict the efficacy and safety of biologics in psoriasis. His research group has collaborated to the discovery of IL-21 as critical mediator of keratinocyte proliferation in psoriasis. Professor Costanzo has authored or co-authored more than 120 publications in internationally peer-reviewed journals.

Disclosures: Professor Costanzo has been a paid consultant for Abbvie, Almirall, Novartis, Lilly, Janssen, UCB, Galderma, Boehringer and Leo Pharma

Professor Peter van de Kerkhof.png

Professor Peter van de Kerkhof

Senior Professor of Dermatology at the Radboud University Nijmegen Medical Centre, Netherlands. Professor Peter van de Kerkhof received honorarium from EPG Health, an IQVIA business, to create content for this resource.

 

 

 

Professor Diamant Thaçi.png

Professor Diamant Thaçi

Professor and Director at the Comprehensive Centre for Inflammation Medicine at the University of Lübeck in Germany, and Chair of the Inflammatory Board at the Lübeck campus of University Hospital Schleswig-Holstein. Professor Thaçi has extensive research experience in the field of immunology, and has been involved in more than 300 clinical trials. Professor Diamant Thaçi received honorarium from EPG Health, an IQVIA business, to create content for this resource.

 

 

Professor Nehal Mehta.pngProfessor Nehal Mehta

Professor Nehal Mehta is a preventive cardiologist and nuclear cardiologist at the National Heart, Blood and Lung Institute in Bethesda, USA. Professor Mehta is an advocate of interdisciplinary cooperation to tackle the issue of comorbidities in patients with psoriasis. Professor Nehal Mehta received honorarium from EPG Health, an IQVIA business, to create content for this resource.

 

 

 

 

Professor Ulrich Mrowietz.pngProfessor Ulrich Mrowietz

Professor Mrowietz is Professor of Dermatology and Head of the Psoriasis-Center at the University Medical Centre in Kiel, Germany.

Professor Mrowietz has extensive experience treating people with psoriasis, and has co-authored recommendations for systemic therapy in persons with psoriasis during the pandemic phase of SARS-CoV-2 (available as an external link).

Professor Ulrich Mrowietz received honorarium from EPG Health, an IQVIA business, to create content for this resource.

 

 

Professor Jordi Quoidbach.png

Associate Professor Jordi Quoidbach

Associate Professor Quoidbach is based in the Department of People Management and Organisation, at Ramon Llull University, in Barcelona, Spain. Quoidbach specialises in emotion and decision-making. Associate Professor Jordi Quoidbach received honorarium from EPG Health, an IQVIA business, to create content for this resource. Professor Quoidbach received honorarium from EPG Health, an IQVIA business, to create content for this resource.

 

 

Piaserico 200 px.png

Professor Stefano Piaserico

Professor Stefano Piaserico is an associate professor at the University of Padua, Italy, and Head of the Regional Centre for Psoriasis. His research is mainly based in dermatology and venereology with a key focus on psoriasis, psoriatic arthritis, organ transplant recipients, photodynamic therapy and skin cancer. He has built up a wide portfolio of more than 160 publications in several scientific journals. He is an associate of numerous professional organisations, including the Italian Society of Dermatology and the European Academy of Dermatology and Venereology (EADV).

 

Julia-Tatjana Maul.jpg

Dr Julia-Tatjana Maul

Dr Maul is Senior Dermatologist and Head of the Psoriasis Clinic and clinical trials team at the University Hospital of Zürich, Switzerland.  Dr Maul is principal investigator of the Swiss Dermatology Network for Targeted Therapy (SDNTT) and has contributed to the Global Psoriasis Atlas (GPA), a 3-month study of psoriasis epidemiology and access to healthcare, for people with psoriasis in South America.  Dr Maul received honorarium from EPG Health, an IQVIA business, to create content for this resource.

 

 

Christian Greis.jpg

Dr Christian Greis

Dr Greis is a dermatologist at the University Hospital of Zürich, Switzerland, and founder of the teledermatology platform derma2go. Dr Greis is currently completing a Master of Business Administration in digital medicine at the Institute for Communication and Leadership (IKF) in Lucerne. Dr Greis received honorarium from EPG Health, an IQVIA business, to create content for this resource.

 

 

Professor Ricardo Romiti

Professor Romiti is a clinical Professor of Dermatology and Head of the Psoriasis Unit at the University Hospital of São Paulo, Brazil. Professor Romiti is responsible for the psoriasis department of the Brazilian Society for Dermatology, a regional coordinator of the Global Psoriasis Atlas in Latin America, and a board member of the International Psoriasis Council. Professor Romiti received honorarium from EPG Health, an IQVIA business, to create content for this resource.

 

 

Andreas Pinter.png

Dr Andreas Pinter

Medical Director of Clinical Research and Senior Physician at the Department of Dermatology, University Hospital of Frankfurt am Main.

 

 

 

Anthony Bewley.png

Professor Anthony Bewley

Consultant Dermatologist at Whipps Cross and Barts. Professor Bewley is also an Honorary Senior Lecturer at Queen Mary Medical School, University of London.

 

 

 

Deepak Balak.png

Dr Deepak Balak

Dr Deepak Balak is a dermatologist at the Department of Dermatology and Allergology of the University Medical Centre Utrecht in Utrecht, the Netherlands, where he combines clinical and teaching responsibilities with a research line focused on chronic inflammatory skin diseases.

His clinical focus is on the impact and management of inflammatory skin diseases, and his scientific interests include translational and pharmacological research for immune-mediated inflammatory skin diseases, such as psoriasis and atopic dermatitis.

 

Wolf-Henning Boehncke.png

Professor Wolf-Henning Boehncke

Professor Wolf-Henning Boehncke is a Full Professor and Head of the Section of Allergy/Immunology at the Department of Dermatology of the Goethe University in Frankfurt, Germany.

Professor Boehncke’s research focuses on clinical and translational projects; namely, in cutaneous inflammation; the current focus of the lab is on the biology of the Interleukin 17 cytokine family. He has published more than 300 peer-review articles.

 

Esteban Daudén.png

Dr Esteban Daudén

Dr Esteban Daudén is a Full Professor in Dermatology at the Autonomous University of Madrid, Spain, and Chief of the Department of Dermatology at the Princess Hospital, Madrid, Spain.

Dr Daudén is a founder member of the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV). He has published over 290 papers in national and international journals, and contributed to 48 books. He has strong research experience from research projects, investigation studies and clinical trials.

 

Luigi Naldi.png

Professor Luigi Naldi

Professor Luigi Naldi is a Professor of Dermatology, Department of Dermatology, Regional Hospital of Vicenza, and GISED Study Centre, Vincenza & Bergamo, Italy. Professor Naldi is head of the Department of Dermatology of the Regional Hospital in Vincenza (Italy). His research interests are general and clinical epidemiology in Dermatology, on methods to assess the safety of medical interventions, and, more recently, on telemedicine and automisation processes in Medicine. Professor Naldi has published more than 360 papers in journals.

 

Laura Savage.png

Dr Laura Savage

 Dr Laura Savage is a Consultant Dermatologist (Leeds Teaching Hospitals NHS Trust) with a special interest in Medical Dermatology and Honorary Senior Lecturer (Faculty of Medicine and Health, University of Leeds). Her research interests cross both dermatology and rheumatology. Dr Savage has a keen interest in hidradenitis suppurativa (HS), and now runs one of a limited number of tertiary HS services in the UK. Dr Savage is an elected committee member of the British Society of Medical Dermatology.

 

 

Peter Weisenseel.png

Dr Peter Weisenseel

Peter Weisenseel is a certified Dermatologist and Allergist with over 15 years of dermatological expertise in chronic inflammatory skin diseases and clinical studies. He is a Senior Doctor at the Dermatologikum Hamburg, and Head of Medical Affairs at SCIderm GmbH, Hamburg. Dr Weisenseel has more than 30 PubMed listed publications.

 

 

Reference

  1. Feldman SR, Goffe B, Rice G, Mitchell M, Kaur M, Robertson D, et al. The challenge of managing psoriasis: Unmet medical needs and stakeholder perspectives. Am Heal Drug Benefits. 2016;9(9):504–512.
Welcome: